LFG
HRMY icon

Larson Financial Group’s Harmony Biosciences HRMY Stock Holding History

Larson Financial Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22
Closed -$823 – 3712
2025
Q4 		$823 Buy
+22
New +$723 ﹤0.01% 3007
2025
Q3 		– Sell
-3
Closed -$95 – 3541
2025
Q2 		$95 Sell
3
-1
-25% -$32 ﹤0.01% 3167
2025
Q1 		$133 Hold
4
– – ﹤0.01% 2871
2024
Q4 		$138 Hold
4
– – ﹤0.01% 2544
2024
Q3 		$160 Hold
4
– – ﹤0.01% 2433
2024
Q2 		$121 Buy
+4
New +$120 ﹤0.01% 2206

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Larson Financial Group's HRMY Position: Q1 2026 in Review

Larson Financial Group sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 22 shares — an estimated $823 sold.

Larson Financial Group first reported a position in HRMY in Q2 2024 and held it in 6 quarters. The position peaked at $823 in Q4 2025. 311 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Larson Financial Group reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Larson Financial Group sold 22 Harmony Biosciences shares in Q1 2026, an estimated $823.
  • Larson Financial Group first reported a position in Harmony Biosciences in Q2 2024 and held it in 6 quarters.
  • Larson Financial Group's Harmony Biosciences position peaked at $823 in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.